STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

21.76B

Vuru Grade

63.43/100

Current Price

$76.55
+0.74 (+0.98%)

Growth Price

$42.87
Overvalued by 44.00%

Stability Price

$7.56
Overvalued by 90.13%

Company Metrics

  • P/E 30.76
  • P/S 3.82
  • P/B 5.25
  • EPS 2.49
  • Cash ROIC 13.51%
  • Cash Ratio 0.27
  • Dividend 1.24 / 1.61%
  • Avg. Vol. 4.06M
  • Shares 284.26M
  • Market Cap. 21.76B

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

St. Jude Medical Inc. (NYSE:STJ) missed earnings on 0 occasions
Zergwatch - 6 hours ago
St. Jude Medical Inc. (NYSE:STJ) is expected to announce second quarter financial results estimated on July 13, 2016.
St. Jude Medical, Inc. (NYSE:STJ) Quarterly Dividend Payout At $-82 Millions - Stocks Daily
St. Jude Medical, Inc. (NYSE:STJ) Analyst Estimates
Zergwatch - Jun 28, 2016
St. Jude Medical, Inc. (NYSE:STJ)stock is currently trading at about $76.12 and lots of rating firms seem to have a target price set on the stock.
Stock Update: St. Jude Medical Inc (NYSE:STJ) - St. Jude Medical Announces ... - Jutia Group (press release) (blog)
St. Jude Medical Announces Second Quarter 2016 Earnings Conference Call - Business Wire (press release)
HC Stocks in the Rumor: Relypsa Inc (NASDAQ:RLYP), St. Jude Medical, Inc ...
share market updates (press release) - 10 hours ago
Shares of Relypsa Inc (NASDAQ:RLYP) ended Tuesday session in green amid volatile trading. The shares closed up +1.57 points or 9.88% at $17.46 with 3.00 million shares getting traded.
Ex-Dividend Reminder: St Jude Medical, Stryker and Zoetis
Forbes - Jun 24, 2016
Looking at the universe of stocks we cover at Dividend Channel, on 6/28/16, St Jude Medical Inc (NYSE: STJ), Stryker Corp. (NYSE: SYK), and Zoetis Inc (NYSE: ZTS) will all trade ex-dividend for their respective upcoming dividends.
Two Buzzers within Analysts Radar: Abbott Laboratories (NYSE:ABT) , St. Jude ...
Street Updates - Jun 28, 2016
St. Jude Medical, Inc. (NYSE:STJ) after beginning at $76.50, closed at $76.12 by cutting down -0.99% in recent trading session.
St. Jude Medical Inc. versus Stryker Corporation Head to Head Compare
CML News - Jun 24, 2016
Stryker Corporation has a higher fundamental rating then St. Jude Medical Inc. which has an impact on the head-to-head comparison.
ST. JUDE MEDICAL INC. (NYSE:STJ) Financial Condition Compared to S&P 500
CML News - Jun 7, 2016
St. Jude Medical Inc. (NYSE:STJ) has a Return on Assets of 7.06%. To compare, the S&P 500 oscillates between 1% and 4%.
HC Stocks Overview: Mylan NV (NASDAQ:MYL), St. Jude Medical, Inc. (NYSE:STJ)
share market updates (press release) - Jun 28, 2016
St. Jude Medical, Inc. (STJ) on June 23, 2016 announced CE Mark approval and launch of SyncAV™ CRT software, designed to build upon the company's first-to-market MultiPoint™ Pacing technology and further optimize St. Jude Medical's comprehensive ...
Stock Positive on the Year: St. Jude Medical Inc. (NYSE:STJ)
The Post - Jun 27, 2016
Year to date, St. Jude Medical Inc. (NYSE:STJ) stock has yielded positive results for investors. So far this year the stock has jumped 25.18% as investors are hopeful that the trend can continue into the 2nd half of 2016.
Earnings Watch: St. Jude Medical Inc. (NYSE:STJ)
CWRU Observer - Jun 14, 2016
St. Jude Medical Inc. (NYSE:STJ) reported earnings for the three months ended March 2016 on April 20, 2016. The company earned $0.9 per share on revenue of $1.45B.
St Jude Medical Inc (NYSE:STJ) near 52-week high, short interest surging - Street Report
St. Jude Medical, Inc. (NYSE:STJ) Analyst Opinion - Zergwatch